Fine Foods & Pharmaceuticals N.T.M. S.p.A.
FF
Rank in Stocks
#17711
Fine Foods & Pharmaceuticals N.T.M. S.p.A. functions as a contract development... Fine Foods & Pharmaceuticals N.T.M. S.p.A. functions as a contract development and manufacturing organization (CDMO), specializing in the creation of various oral solid forms for the pharmaceutical and nutraceutical sectors. Its pharmaceutical offerings include items such as powders, granules, capsules, standard and film-coated tablets, effervescent granules, and hard gelatine capsules. For the nutraceutical market, the company produces soluble, effervescent, and chewable tablets, fast-melting/sublingual tablets, film-coated tablets, and hard gelatine capsules, alongside soluble and effervescent powders and granules. These nutraceutical products are designed to support a wide range of health needs, encompassing areas like probiotics, multivitamins and minerals, immune system function, sleep and relaxation, gastrointestinal and circulatory health, osteoarticular and urinary systems, women's health, beauty, healthy aging, and mental wellbeing. In addition to its core CDMO services, the company also manufactures and sells a diverse array of cosmetic products, covering hair care, skin care, liquid personal hygiene items, oral hygiene products, deodorants, alcohol-based perfumery, bath and shower gels, shampoos and conditioners, shaping waxes, mouthwashes, creams, gels, and toothpastes. Furthermore, they supply medical surgical aids and devices, various antiseptics for intact skin, hand sanitizers, pre-injection solutions, hydroalcoholic surface cleaners, and iodine. Their product line also extends to orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. Established in 1984, the company is headquartered in Verdellino, Italy.
Share Price
$6.73
Last synced: 2026-11-09
Market Cap
$158.40M
Change (1 day)
-1.94%
Change (1 year)
-37.90%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF)
Category
Consumer Defensive
EPS for Fine Foods & Pharmaceuticals N.T.M. S.p.A. (FF)
EPS as of June 2026 TTM: $-0.07
According to Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s latest financial reports, its current EPS (TTM) is $-0.07. At the end of 2025 the company had an EPS of $0.47, an increase over its 2024 EPS of $0.33.
EPS history for Fine Foods & Pharmaceuticals N.T.M. S.p.A. from 2016 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.07 | -115.53% |
| 2025 | $0.47 | 40.93% |
| 2024 | $0.33 | -315.12% |
| 2023 | $-0.15 | -61.00% |
| 2022 | $-0.40 | 485.40% |
| 2021 | $-0.07 | -109.60% |
| 2020 | $0.71 | -624.81% |
| 2019 | $-0.13 | -113.78% |
| 2018 | $0.98 | -4,519.91% |
| 2017 | $-0.02 | 9.95% |
| 2016 | $-0.02 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $3.49 | -4,879.04% |
CH
|
|
| $3.40 | -4,759.18% |
FR
|
|
| $2.37 | -3,346.58% |
BR
|
|
| $0.24 | -422.60% |
CN
|
|
| $0.18 | -348.63% |
CN
|
Questions about Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS)
What is Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS)?
Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) over the last twelve months is $-0.07, as of Jun 2026.
What was Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) in 2025?
In 2025, Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) was $0.47, 42.42% more than in 2024 ($0.33).
How has Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) went from $0.71 to $0.47, an average decline of 7.92% a year.
How does Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) compare with similar companies?
Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s earnings per share (EPS) ($-0.07) is lower than that of all 5 similar companies listed above. The highest among them is Nestlé S.A., with $3.49.